Back to search

Pathios Therapeutics Limited

10641754

active
ltd
england wales
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)

Details

99 Park Drive, Milton, Abingdon, OX14 4RY
Incorporated 27/02/2017

Compliance

Last accounts

31/12/2025

small

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 26/02/2026

Due 12/03/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Thomas David Mccarthy

director · Since 27/02/2017

COMPANY DIRECTOR

AUSTRALIAN · UNITED KINGDOM · Age 59

Also on 2 other boards

Mr Brenton Karl Ahrens

director · Since 28/08/2019

VENTURE CAPITAL INVESTOR

AMERICAN · UNITED STATES · Age 63

Also on 1 other board

Christopher Dean Nave

director · Since 09/09/2019

VENTURE CAPITALIST

AUSTRALIAN · AUSTRALIA · Age 51

Ms Samantha Ann Harris

secretary · Since 15/06/2022

Mr Paul Grant Higham

director · Since 07/06/2024

BIOTECH EXECUTIVE

BRITISH,GERMAN · GERMANY · Age 63

Dr Jon Wigginton

director · Since 14/07/2025

BIOTECH DRUG DEVELOPMENT

AMERICAN · UNITED STATES · Age 64

Thomas David Mccarthy

director · Since 27/02/2017

Australian · United Kingdom · Age 59

Brenton Karl Ahrens

director · Since 28/08/2019

American · United States · Age 63

Christopher Dean Nave

director · Since 09/09/2019

Australian · Australia · Age 51

Samantha Ann Harris

secretary · Since 15/06/2022

Paul Grant Higham

director · Since 07/06/2024

British,German · Germany · Age 63

Jon Wigginton

director · Since 14/07/2025

American · United States · Age 64

Former

Someit Singh Sidhu

director · Resigned 28/08/2019

John Francis Unitt

director · Resigned 28/08/2019

Kirsty Ann Mccarthy

secretary · Resigned 15/06/2022

Stuart Wynn Hughes

director · Resigned 07/06/2024

Jeanmarie Guenot

director · Resigned 06/03/2025

Persons with Significant Control

Former PSCs

Dr Someit Singh Sidhu

Ceased 29/10/2018

Canaan Xi L.P.

Ceased 28/08/2019

Change History

officer appointedHARRIS, Samantha Ann
2026-08-07
officer appointedAHRENS, Brenton Karl
2026-08-07
officer appointedHIGHAM, Paul Grant
2026-08-07
officer appointedMCCARTHY, Thomas David
2026-08-07
officer appointedNAVE, Christopher Dean
2026-08-07
officer appointedWIGGINTON, Jon, Dr
2026-08-07
statusactive
2026-08-07

Active

typeltd
2026-08-07

Private Limited Company

address line199 Park Drive
2026-08-07

99 PARK DRIVE

post townAbingdon
2026-08-07

ABINGDON

CompanyRankvs 134+ SIC 72110 peers
83

Financial strength97th percentile among SIC peers · 24/25
Employees90th percentile among SIC peers · 14/15
LiquidityCurrent ratio 7× · 20/20
Longevity10 years trading (max 15) · 10/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity10/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£4.8M

Balance sheet strength

Cash

£3.3M

Cash in the bank

Net Current Assets

£4.1M

Working capital

Current Assets

£4.7M

Current Liabilities

£677k

Fixed Assets

£782k

Debtors

£1.5M

Profit After Tax

-£6.1M

8avg. employees
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20247.00+£1.1M
20236.35

Derived from filed accounts. Not audited figures.